Literature DB >> 2311443

Comparative ototoxicity of ribostamycin, dactimicin, dibekacin, kanamycin, amikacin, tobramycin, gentamicin, sisomicin and netilmicin in the inner ear of guinea pigs.

I Kitasato1, M Yokota, S Inouye, M Igarashi.   

Abstract

Nine aminoglycoside antibiotics, ribostamycin (RSM), dactimicin (DAC), dibekacin (DKB), kanamycin (KM), amikacin (AMK), netilmicin (NTL), tobramycin (TOB), gentamicin (GM) and sisomicin (SISO) were administered intramuscularly to guinea pigs for 4 weeks, and ototoxicity and drug concentration in the inner ear fluid were determined. RSM and DAC showed the weakest ototoxicity against the cochlea and vestibular organs. AMK and KM were more toxic to cochlea than vestibular organs. DKB, TOM, GM and SISO were equally toxic to vestibular organs and cochlea. NTL was more toxic to vestibular organs than cochlea. As judged from the pinna reflex response and hair cell damage in the cochlea, the order of auditory toxicity was the following: SISO greater than GM greater than TOB greater than AMK greater than DKB greater than KM greater than NTL, DAC RSM, whereas the vestibular toxicity was in the following order: SISO greater than GM greater than DKB greater than TOB greater than NTL greater than AMK greater than KM greater than DAC, RSM. RSM, causing the weakest ototoxicity, showed a low drug concentration in the inner ear fluid, while GM, causing severe ototoxicity, showed the highest drug level under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311443     DOI: 10.1159/000238762

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  High-frequency auditory feedback is not required for adult song maintenance in Bengalese finches.

Authors:  S M Woolley; E W Rubel
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

2.  A new immunohistochemical method for the detection of gentamicin in inner ear fluid compartments.

Authors:  M Mihelic-Rapp; W Giebel
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 3.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

4.  Phospholipon 90H (P90H)-based PEGylated microscopic lipospheres delivery system for gentamicin: an antibiotic evaluation.

Authors:  Mumuni Audu Momoh; Charles Okechukwu Esimone
Journal:  Asian Pac J Trop Biomed       Date:  2012-11

Review 5.  Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.

Authors:  C A Lindsay; J A Bosso
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

6.  An Evaluation of the Protective Effects of Thymoquinone on Amikacin-Induced Ototoxicity in Rats.

Authors:  Fadlullah Aksoy; Remzi Dogan; Orhan Ozturan; Selahattin Tugrul; Bayram Veyseller; Omer Faruk Ozer; Alev Pektas
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-11-10       Impact factor: 3.372

Review 7.  Experimental animal models of drug-induced sensorineural hearing loss: a narrative review.

Authors:  Xuexin Lin; Jia Luo; Jingqian Tan; Luoying Yang; Mitian Wang; Peng Li
Journal:  Ann Transl Med       Date:  2021-09

8.  Persistence of the otoprotective effect: how long does otoprotection against amikacin lasts?

Authors:  Andreia Ardevino de Oliveira; Matheus de Souza Campos; Adriana de Andrade Batista Murashima; Maria Rossato; Miguel Angelo Hyppolito; José Antônio Apparecido de Oliveira
Journal:  Braz J Otorhinolaryngol       Date:  2012-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.